الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 131 |  |  |
| | | from | 131 | | |
Abstract
E
RAS is a multimodal program that targets early mobilization and early oral feeding after major surgery thus early discharge with less morbidity. This is achieved by normalizing the patient’s physiologic state preoperatively to decrease the impact of surgery which helps early returning to the normal state
ERAS pathway starts from the preoperative period throughout the whole perioperative hospital stay. Preoperatively it aims to prepare the patient for the upcoming surgical stress in order to decrease the impact of metabolic response
Present study involved 80 patients who were candidates for general surgical intervention. They were randomly divided into 2 equal groups according to the perioperative protocol offered to them. group A included 40 (50%) patients assigned for the conventional recovery protocol and group B included 40 (50%) patients assigned for the ERAS pathway. There was a non-significant difference between the two study groups regarding demographic and general clinical data.
Operative and postoperative data:
Patients of both groups passed the procedure efficiently without any intraoperative complications.
The mean operative time was 155 minutes in control group and 160 minutes in ERAS group, this wasn’t statistically significant (P>0.05). The mean amount of blood loss was 150 ml in control group and 175 ml in ERAS group which was also insignificant (P>0.05).
Postoperative outcomes:
Postoperative outcomes among patients who were managed through the ERAS pathway showed a highly significant difference in the length of postoperative hospital stay in comparison with patients who were managed through conventional perioperative protocol.
Mean length of hospital stay (LOS) was 3.05 in group A versus 1.2 in group B which was highly significant (P<0.001).
Postoperative patient self-stated pain scores revealed a highly significant lower mean pain scores among patients managed through ERAS compared with controlled group (P<0.001).
Patients in the ERAS group had a shorter time to first flatus than the control group, and this was statistically highly significant. Incidence of postoperative nausea and vomiting (PONV) was less in group B, and this was also highly significant. As regards re-admission and re-operation there was no any significant difference between both groups. There was no mortality during the follow-up period in both groups.